Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCP-Tacro vs Prograf in Stable Kidney Transplant Patients
NCT00496483Phase 2Completed
- Sponsor
- Veloxis Pharmaceuticals
- Start
- Jul 2007
- Primary completion
- Mar 2008
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Envarsus XR in kidney transplantation, sponsored by Veloxis Pharmaceuticals. Started Jul 2007; status: completed.
02
Drugs
Envarsus XR
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00496483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496483.